
Analysts initiated coverage on FE, ACCV, XE and ETRA, issuing Buy, Outperform, Equal-Weight and Hold ratings with targets up to $50.
ETRA is up 5.63% today. Volume is 65.5K vs a 30-day average of 669.4K (0.10x).

Analysts initiated coverage on FE, ACCV, XE and ETRA, issuing Buy, Outperform, Equal-Weight and Hold ratings with targets up to $50.
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Buy rating and announces Price Target of $30.

Gainers Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 29.7% to $0.42 during Friday's pre-market session. The company's market cap stands at $63.6 million. Elect…
JP Morgan analyst Anupam Rama initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Overweight rating and announces Price Target of $36.